Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2008
11/11/2008US7449485 N-sulfonylurea apoptosis promoters
11/11/2008US7449481 Thio-substituted biaryl-methanesulfinyl derivatives
11/11/2008US7449480 Small molecule inhibitors of HER2 expression
11/11/2008US7449467 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449460 3-Quinolinecarbonitrile protein kinase inhibitors
11/06/2008WO2008134474A2 Compositions and methods including cell death inducers and procaspase activation
11/06/2008WO2008133900A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/06/2008WO2008133288A1 Tricyclic aryl compounds
11/06/2008WO2008133198A1 Neurite formation promoter
11/06/2008WO2008131947A1 Substituted sulfonamide derivatives
11/06/2008WO2008131946A2 Substituted amide derivatives
11/06/2008WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
11/06/2008US20080275127 Arylsulfonamido-substituted hydroxamic acid derivatives
11/06/2008US20080275087 Biphenylcarboxamides useful as lipid lowering agents
11/06/2008US20080275086 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275003 Phospholipase inhibitor; prevention or therapy of microbial infection; bactericides; fungicides; viricides; parasiticides; using quaternary or phosphonium group containing compounds
11/06/2008US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
11/06/2008US20080274891 Pyridine-3-ketone compound; plant growth controllers
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685567A1 Pyridonecarboxamides, crop protection agents containing the same, method for production and use thereof
11/06/2008CA2685507A1 Substituted sulfonamide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/06/2008CA2684561A1 Neurite formation promoter
11/06/2008CA2682032A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists
11/05/2008EP1988078A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
11/05/2008EP1987717A1 Pyridon carboxamides, agents containing these but not impacting useful plants and method for their manufacture and application
11/05/2008EP1987001A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
11/05/2008EP1987000A2 Diaryl piperidines as cb1 modulators
11/05/2008EP1638980B1 Process for preparing 3-aminothienopyridone derivatives
11/05/2008EP1608374B1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
11/05/2008EP1499596B1 Muscarinic antagonists
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/05/2008CN100430379C Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/05/2008CN100430378C New piperidine derivative
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446204 Amino substituted aryloxybenzylpiperidine derivatives
11/04/2008US7446203 Preparation of intermediates for acetycholinesterase inhibitors
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446104 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
10/2008
10/30/2008WO2008131368A2 Styrenyl derivative compounds for treating ophthalmic diseases and disorders
10/30/2008WO2008130319A2 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
10/30/2008WO2008080601A3 Process for the preparation of loperamide
10/30/2008WO2007126362A8 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
10/30/2008US20080269494 Process for the Preparation of Alpha-Aryl-Alpha-Piperid-2-Yl-Acetamides and the Acid Hydrolysis Thereof
10/30/2008US20080269294 Benzamide Compounds Useful as Histone Deacetylase Inhibitors
10/30/2008US20080269290 Indoles
10/30/2008US20080269289 Vanilloid receptor ligand compounds, pharmaceutical compositions containing them, a method of producing them and the use thereof to treat pain and various other conditions
10/30/2008US20080269287 Substituted Pyridone Derivative
10/30/2008US20080269286 Disubstituted Phenylpiperidines as Modulators of Cortical Catecholaminergic Neurotransmission
10/30/2008US20080269285 Use of these iminoxylitol compounds for treatment of Gaucher's disease
10/30/2008US20080269275 Moderation of melanocyte stimulating hormone; psychological disorders; analgesics; anxiolytic agents; bipolar disorders;obesity; eating disorders; antidepressants
10/30/2008US20080269255 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
10/30/2008US20080269250 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists
10/30/2008US20080269221 Antibacterial agents
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269190 Chronic obstructive pulmonary disease; asthma
10/29/2008EP1984336A2 Process for synthesizing remifentanil
10/29/2008EP1984330A1 Chemical compounds
10/29/2008EP1983986A2 Piperidine derivatives as cxcr3 receptor antagonists
10/29/2008EP1863872B1 Novel polymeric hindered amine light stabilizers based on end functionalized polyolefins and a process for the preparation thereof.
10/29/2008EP1562979B1 Tubulysins, method for producing the same and tubulysin preparations
10/29/2008CN101296914A Derivative having PPAR agonistic activity
10/29/2008CN101296902A Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442796 oxo-acids such as [3-(2,6-Dimethylbenzyloxy)-phenyl]-oxoacetic acid, used for treating insulin resistance, diabetes, hyperlipemia, liver disorders, cachexia, obesity, atherosclerosis and arteriosclerosis
10/28/2008US7442714 3-ethyl-5-methyl-2-(2-aminoethoxy-methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarboxylate gentisate; crystalline acid salt; low toxicity, excellent stability, improved pharmaceutical efficacies and long-lasting concentration in blood; cardiovascular diseases, hypotensive agent
10/28/2008US7442711 Amelioration of the development of cataracts and other ophthalmic diseases
10/28/2008CA2359027C S-nitrosothiols as agents for the treatment of circulatory dysfunctions
10/28/2008CA2152979C Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
10/23/2008WO2008127223A1 Cyclopropanes with central nervous system activity
10/23/2008WO2008127188A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008WO2008126995A1 A process for preparing intermediate of donepezil
10/23/2008WO2008125570A1 New bradykinin b1 antagonists
10/23/2008WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008101907A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2008US20080262234 Reacting secondary amine, carbon dioxide, triarylsilyl chloride and halogenation agent
10/23/2008US20080262230 Tachykinin receptor anatgonist; good transfer into blood; long half-life; stability; bradycardial agents; antiinflammatory agents ; antallergens; analgesics; antiemetics; irritable bowel disorders; skin disorders; antidepressants; antiischemic agents ; anxiolytic agents; autoimmune diseases; muscle relax
10/23/2008US20080262227 Process for making risperidone and intermediates therefor
10/23/2008US20080262226 Methods of making compounds having a beta-adrenergic inhibitor and a linker and methods of making compounds having a beta-adrenergic inhibitor, a linker and a phosphodiesterase inhibitor
10/23/2008US20080262040 novel indazole carboxamide derivatives for inflammatory and tissue repair disorders like rheumatoid arthritis, asthma, and COPD; kinase inhibitors in particular IKK2; 1,1-dimethylethyl-4-[4-(aminocarbonyl)-6-phenyl-1H-indazol-1-yl]-1-piperidinecarboxylate; intermediates
10/23/2008US20080262039 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process For Making Them, and Use Thereof For Treating Pain and Other Conditions
10/23/2008US20080262038 4-[(4-aminophenyl)(1-benzylpiperidin-4-ylidene)methyl]-N,N-diethylbenzamide; management of pain, anxiety and functional gastrointestinal disorders; delta agonist
10/23/2008US20080262037 Piperidine Derivatives for the Treatment of Chemokine Mediated Disease
10/23/2008US20080262016 Isoquinoline derivatives and methods of use thereof
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261985 treating a disorder characterized by the overexpression of iNOS or COX-2 genes; rheumatoid arthritis, inflammatory bowel disease, lupus, multiple sclerosis, or psoriasis; cancer
10/23/2008US20080261978 treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers; 1-(4-((pyridin-2-ylmethylamino)methyl)benzyl)-3-phenylurea
10/23/2008US20080261956 Substituted Phenols as Active Agents Inhibiting Vegf Production
10/23/2008US20080260651 Contrast agents
10/23/2008CA2683719A1 N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
10/23/2008CA2674451A1 Process of enantiomeric resolution of d,l-(plus/minus)-threo-methylphenidate
10/22/2008EP1981873A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
10/22/2008EP1981848A2 11-beta hsd1 inhibitors
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 380